对于多模式癌症生存分析的队列-个人合作学习
IEEE transactions on medical imaging
|September 6, 2024
概括
这项研究引入了使用多式联络数据进行癌症存活率分析的新框架. 队列-个体合作学习 (CCL) 模型通过分解和融合来自不同数据类型的知识来提高预测准确性.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
背景情况:
- 癌症存活率分析从整合多式联络数据 (如病理图像和基因组资料) 中获益.
- 多式数据的异质性和高维度对提取歧视性表示和确保概括性提出了挑战.
研究的目的:
- 为增强癌症存活率分析提出一个队列-个体合作学习 (CCL) 框架.
- 解决多式联运数据集成方面的挑战,以提高预测准确性和模型概括性.
主要方法:
- 开发了一个多式联网知识分解 (MKD) 模块,将多式联网知识分成冗余,协同和独特性组件.
- 实施了队列指导建模 (CGM),以防止过度匹配,并通过利用队列级信息来增强概括.
主要成果:
- 拟议的CCL框架有效地整合了用于癌症生存率分析的多式联络数据.
- 五个癌症数据集的实验结果表明,歧视和概括能力的显著改善.
- 该模型成功地从异质和高维多态数据中提取了歧视性表示.
结论:
- CCL框架为多模式癌症存活率分析提供了一个强大的方法.
- 知识分解和队列指导的结合提高了模型的性能和可靠性.
- 这种方法为在精密瘤学中利用多式联络数据提供了一个有希望的方向.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Assumptions of Survival Analysis
111
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
111
Kaplan-Meier Approach
111
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
111
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


